European Regulation: Developments, Deadlines and Key Areas for Action
This page provides a concise overview of the most important regulatory developments across the European Union and highlights the requirements that will become relevant for companies in the medical device, pharmaceutical and life sciences sectors between 2026 and 2027.
Four Key EU Regulatory Areas Companies Should Address Now
European regulatory developments through the end of 2027 affect different areas of business, yet in practice they are often closely interconnected. A robust assessment therefore requires companies to consider deadlines, product requirements, quality processes and documentation obligations together.
The PPWR generally applies from 12 August 2026. From this date, particular attention must be paid to PFAS limits for food-contact packaging as well as requirements relating to certain heavy metals. Other requirements, including recyclability, labelling and reuse, will take effect gradually at later dates. Reusable packaging must also comply with the applicable requirements. Companies should therefore review material data, supplier documentation, packaging concepts and their respective role as manufacturer, importer or distributor, and prepare the necessary compliance documentation.
The extended transitional periods under the MDR and IVDR apply only if the relevant conditions were fulfilled within the required deadlines. The IVDR is particularly relevant at present: for certain Class C legacy IVDs, the formal application to a Notified Body had to be submitted by 26 May 2026. In addition, the written agreement with the Notified Body must be concluded by 26 September 2026 at the latest. Without meeting these conditions, the extended transitional period until the end of 2028 cannot be used. The corresponding deadlines for Class B and Class A sterile devices follow in 2027. Manufacturers should therefore review their certification status, existing agreements and the involvement of their Notified Body now.
Regulation (EU) 2023/1230 replaces the previous Machinery Directive and introduces directly applicable requirements for machinery, related products and partly completed machinery. Greater emphasis is placed on safety-related software, connected functions and risks arising from digital technologies. Operators and manufacturers must also assess when modifications to existing machinery qualify as a substantial modification and therefore require renewed conformity assessment.
The revised Annex 19 applies from 24 September 2026. It sets out requirements for the collection and retention of reference samples from starting materials, packaging materials and finished products, as well as retention samples of fully packaged medicinal products. The revised requirements provide greater clarity in particular for parallel-imported, parallel-distributed or parallel-traded products and their repackaging.
Not every regulatory development affects every company to the same extent. Key factors include the product portfolio, role within the supply chain, target markets, packaging used, technical systems and existing quality processes.
Key EU Deadlines from August 2026 to the End of 2027
Not every regulatory date immediately creates an obligation for companies to take action. Effective planning requires a clear distinction between binding application dates, specific product and company deadlines, and deadlines that primarily apply to Member States or the European Commission.
Not Every Date Is a Company Deadline
The regulatory impact depends on whether legislation becomes directly applicable, a specific transitional requirement must be fulfilled, or Member States or the European Commission must first take action.
The New EU Regulatory Framework Begins to Take Effect
Regulation (EU) 2025/40 on packaging and packaging waste generally applies from this date. Companies must classify their packaging by packaging level, material, intended use and their own role as an economic operator. Specific provisions for pharmaceutical or medical device packaging must be assessed requirement by requirement; there is no general sector-wide exemption.
The revised version clarifies the requirements for reference and retention samples. Key areas to review include sampling plans, collection and retention, storage conditions, traceability and the allocation of responsibilities between manufacturers, importers, marketing authorisation holders and external storage sites.
From this date, the national provisions implementing Directive (EU) 2024/825 must be applied. Generic environmental claims, sustainability labels and certain climate-related advertising claims will be subject to significantly stricter rules. Companies should review product labelling, packaging and sustainability communications to ensure that claims are permissible and supported by robust evidence.
Product Liability, Machinery Regulation and PPWR Enforcement
Member States must transpose Directive (EU) 2024/2853 into national law. The new framework expressly covers software and digital elements of products. Key considerations for companies include technical documentation, evidence and recordkeeping, product modifications, software updates and contractual interfaces with suppliers.
Regulation (EU) 2023/1230 replaces the previous Machinery Directive. Companies must correctly distinguish between machinery, related products and partly completed machinery, and align risk assessments, technical documentation, conformity assessment and operating instructions with the new regulatory framework.
Member States must establish rules on penalties and notify the European Commission. Although the substantive PPWR requirements apply across the EU, enforcement, competent authorities and penalty practices may differ between Member States.
IVDR, UDI, Environmental Regulation and SoHO
To benefit from the extended transitional period, a formal application must have been submitted to a Notified Body. The separate QMS requirement had already to be fulfilled by 26 May 2025 and is therefore no longer an outstanding task for 2027.
This date is particularly relevant for Class A IVDs and for direct marking requirements applicable to certain reusable Class I medical devices. Labels, packaging, master data, production processes and associated registration data must be aligned consistently.
The Commission must evaluate the application of both regulations. These reports may pave the way for future amendments to the regulatory framework, but they do not automatically change the requirements or transitional periods applicable up to that point.
Directive (EU) 2024/3019 establishes, among other measures, a framework for extended producer responsibility for the pharmaceutical and cosmetics sectors to finance advanced wastewater treatment. 31 July 2027 is initially a transposition deadline for Member States and does not automatically represent an immediate payment deadline for every company.
Regulation (EU) 2024/1938 governs activities involving substances of human origin. Depending on the activity and organisation, relevant areas include authorisations, quality management systems, vigilance, traceability and the protection of donors and recipients.
IVDR Agreement Deadline and the End of Key Transitional Periods
Following the application deadline of 26 May 2027, a written agreement on conformity assessment must be signed between the manufacturer and the Notified Body. The application and the written agreement are two separate requirements for benefiting from the extended transitional provisions.
For the relevant legacy devices, the extended transitional period ends, provided the applicable conditions were met and no specific exemption applies. Certification status, product modifications, inventory and continuity of supply must be reliably secured by this date.
The extended transitional period ends for the highest IVD risk class. Key requirements include a secured conformity assessment status, a complete performance evaluation, effective PMS and PMPF processes, and robust planning to ensure continued product supply.
Four Key EU Dates Requiring Direct Implementation Action
These deadlines either mark the direct application of new EU legislation or represent a specific prerequisite for maintaining the marketability of existing products. Preparation should therefore be product-specific rather than limited to general corporate policies.
Packaging matrices, economic operator roles, material data and potential exemptions must be documented in a robust and traceable manner.
Product classification, risk assessment, technical documentation and conformity assessment procedures must be aligned with the new regulatory framework.
For Class B and Class A sterile devices, both the application and the agreement with the Notified Body must be completed on time as separate requirements.
The extended transitional period ends for certain high-risk MDR devices and Class D legacy IVDs.
Where Regulatory Changes Directly Affect Your Organisation
Relevant EU requirements extend far beyond regulatory documentation. Depending on the product, the company’s role and its supply chain, they can have a direct impact on quality processes, product files, packaging specifications, supplier agreements, machinery and digital systems.
Quality Management and Organisation
New regulatory requirements must be integrated into the existing QMS structure. This involves not only procedures, but also approval workflows, responsibilities, training requirements and change management. A key consideration is where new evidence and records are created, reviewed and maintained on an ongoing basis.
Products and Technical Documentation
Under the MDR, IVDR and Machinery Regulation, the applicable regulatory status and the documentation supporting that status must be clearly traceable for each affected product. Adjustments may be required in areas such as classification, conformity evidence, product registration, labelling, instructions for use and technical documentation.
Packaging, Procurement and Supply Chain
The PPWR applies not only to sales packaging, but also to secondary, grouped and transport packaging. Companies therefore need to review not only packaging design, but also material data, recyclability, labelling, supplier documentation and existing specifications. Changes in materials may in turn trigger approvals, stability assessments or change control procedures.
Technical Systems and Digital Components
For machinery and connected systems, technical, regulatory and software-related requirements must be assessed together. The Machinery Regulation places greater emphasis on safety-related software and digital functions. Changes to control systems, connectivity or software can therefore affect risk assessments, technical documentation and conformity assessment.
Regulatory Requirements Often Affect the Same Products and Processes
Packaging changes, for example, can affect technical documentation, supplier management and change control at the same time. Changes to machinery or software can likewise influence risk assessments, conformity evidence and internal responsibilities. A coordinated assessment helps prevent individual departments from addressing the same regulatory change independently of one another.
Turning Regulatory Requirements into a Robust Implementation Plan
Regulatory changes should not be passed on to individual departments only shortly before the relevant deadline. Robust implementation begins by identifying the products and processes affected, continues with a documented gap analysis and results in approved measures, clearly assigned responsibilities and verifiable evidence.
Three Workstreams Instead of Isolated Individual Measures
The PPWR, MDR and IVDR, the Machinery Regulation and EU GMP Annex 19 affect different products and company roles. Yet the implementation approach follows a common logic: first, determine the specific scope of application; next, assess gaps and dependencies; and finally, translate the required changes into controlled updates to processes and documentation.
Clarify Scope and Applicability
The first step is to determine which products, roles, sites and processes are actually affected.
Assessment Starts with the Specific Use Case, Not the SOP
Under the PPWR, for example, distinctions must be made by product, packaging level, material and economic operator role. Under the MDR and IVDR, product class, legacy status, certificate, Notified Body and applicable transitional provision are decisive. Under the Machinery Regulation, machinery, partly completed machinery, related products and safety-related software must be clearly distinguished.
Assess Gaps and Dependencies
Requirements must be compared with existing documents, systems and contractual arrangements.
Individual Changes Often Affect Several Systems at the Same Time
A new packaging specification can affect supplier documentation, stability assessments, labelling and change control. An IVDR deadline can simultaneously affect technical documentation, agreements with the Notified Body and continuity of supply. Changes to machinery or software may alter risk assessments, operating instructions, conformity procedures and responsibilities across Engineering, IT and Quality.
Secure Implementation and Evidence
Measures need clear ownership, deadlines, approvals and a traceable conclusion.
Compliance Is Achieved through Effective and Verifiable Implementation
The action plan must distinguish between one-off project tasks and processes that require ongoing operation. This may include updated technical documentation, supplier agreements, sampling plans, new approval workflows, training or recurring monitoring activities. Completion should be secured through technical review, formal approval and documented effectiveness checks.
What Needs to Be Addressed for Each Regulatory Framework
The underlying implementation methodology is comparable. However, the required evidence and the departments involved can differ considerably.
Packaging levels, materials, roles, exemptions, labelling and supplier data.
A robust packaging matrix, updated specifications, supplier evidence and controlled change management.
Product status, classification, transitional provisions, certificates, applications and agreements with Notified Bodies.
A product-specific deadline overview, complete evidence chain and secured conformity or transitional status.
Product classification, risk assessment, software functions, technical documentation and conformity assessment procedures.
Updated risk assessments, technical documentation, operating instructions and clearly defined engineering interfaces.
Reference and retention samples, storage conditions, retention periods, access and responsibilities.
A revised sampling strategy, clearly assigned responsibilities, robust storage records and updated agreements.
Not Every Gap Has the Same Level of Urgency
Prioritisation should consider whether a deadline affects continued market access, whether long external lead times are involved and whether the change affects several products or sites at the same time.
Secure certifications, applications, agreements and binding application dates first.
Start packaging changes, supplier changes and technical modifications at an early stage.
Permanently integrate SOPs, training, roles and recurring controls into the QMS.
Which EU Requirements Specifically Affect Your Company?
We support you in assessing regulatory requirements, conducting gap analyses and translating requirements into practical measures, processes and verifiable evidence. For a specific regulatory question, you can contact us directly or use our free initial expert assessment through Express Consulting.
Your Direct Contact
I am happy to assist you personally.